Hormones for Superovulation in Sheep

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Wenmin Cheng	--	1501	2022-04-14 04:00:30	\|
2	format correct	Catherine Yang	Meta information modification	1501	2022-04-14 04:52:56	\| \|
3	rollback to version 1	Catherine Yang	Meta information modification	1501	2022-04-21 10:37:17	\| \|
4	format correct	Catherine Yang	Meta information modification	1501	2022-04-21 10:39:45	\|

This entry is adapted from the peer-reviewed paper 10.3390/vetsci9030117

Superovulation is typically achieved using gonadotropic hormone preparations that promote the development of subordinate follicles in order to ovulate, or through inhibin immunization to eliminate the inhibitory mechanism of the dominant follicle. Various gonadotropic preparations (FSH and eCG) are widely applied to induce superovulation in sheep. Other hormones, such as horse anterior pituitary (HAP) extracts, human menopausal gonadotropin (hMG), gonadotropin-releasing hormone (GnRH), and human chorionic gonadotropin (hCG) have also been applied, although less frequently, during sheep superovulation.

hormonal protocols

1. FSH and Superovulatory Response

FSH is the most commonly used hormone for inducing superovulation in sheep and other livestock ^[1]^[2]. Generally, it is administered via multiple injections (6–10) at 12 h intervals over a period of 3–5 days during the follicular phase ^[3]^[4]^[5]. Variation in ovarian response to this procedure has been observed in sheep (Table 1). Collectively, maximum rates of ovulation (15.9) and embryo recovery (10.7) were observed using the conventional FSH protocol ^[6]. The major disadvantage of FSH is its short half-life, necessitating daily administration ^[7]^[8]^[9]. In addition, multiple injections are time consuming and stressful for animals, which may be detrimental to the female reproductive performance ^[6]. Furthermore, the potential for premature luteal regression, substantial individual variability in ovarian responses, and the low quality of recovered embryos, are also limiting factors of FSH ^[2]^[10].

Table 1. Comparative ovarian responses of simplified and traditional superovulation protocols.

Breed	Superovulation Protocol	OR ¹	ER ²	FR ³ (%)	TRR ⁴	References
Awassi breed	FSH decreasing doses	8.75 ± 0.4 ^ac	4.83 ±0.6	-	-	^[11]
	eCG 1200 IU, single dose	5.66 ± 0.4 ^bd	4.66 ± 0.6 ^a	-	-	^[11]
Corriedale and Bond	In simplified protocol, FSH 180 mg	10.2 ± 3.4	9.9 ± 3.6	52.5	5.1 ± 4.9	^[7]
Corriedale and Bond	6 FSH administered twice daily	10.8 ± 4.7	10.5 ± 5.2	37.1	2.9 ± 2.9
Corriedale	oFSH + eCG, single injection	13.8 ± 1.9 ^a	8.4 ± 1.4 ^a	64.2 ^b	-	^[1]
	oFSH dissolved in saline, divided into 4 equal doses	6.2 ± 1.1 ^b	3.1 ± 1.1 ^b	45.9 ^b	-
	oFSH dissolved in 30% polyvinylpyrrolidone, single dose	4.7 ± 1.0 ^b	3.2 ± 1.1 ^b	89.7 ^a	-
	oFSH 72 h before and 12 h after sponge removal, 8 decreasing doses	10.7 ± 0.9 ^a	5.5 ± 0.8	93.9	-
Fine wool Merino	FSH,7 decreasing doses 48 h before sponge removal during breeding and non-breeding season	13.9 ±0.8 ^a 11.3 ±1.8 ^a	6.0 ± 0.5 ^a 3.5 ± 1.0 ^b	-	-	^[12]
	FSH 70 mg + eCG, single dose 48 h before sponge removal during breeding and non-breeding season	3.2 ± 1.2 ^b 6.0 ± 1.1 ^b	1.2 ± 0.6 ^b 1.6 ± 0.5 ^b	-	-
Merino breed	eCG + 11.5 mg pFSH, 6 decreasing doses	14.2±1.2 ^a	5.2± 1.9 ^a	58.3 ^a	-	^[13]
	eCG, 1200 IU	6.2 ± 0.8 ^b	1.0 ± 0.5 ^b	26.3	-
	eCG, 1600 IU	11.0 ± 3.0 ^ab	1.2± 0.6 ^b	19.2	-
Ojalada	280 IU pFSH, 6 decreasing doses	15.9 ± 2.0 ^a	10.7± 1.7 ^a	86 ^a	-	^[6]
	210IU pFSH + 500 IU eCG, single dose	14.5 ± 2.1 ^a	11.3 ± 1.8	76 ^a	-
Sarda	250 IU pFSH, 4 decreasing doses	11.8 ± 4.0 ^a	8.80 ^c	81.7	-	^[14]
	125 IU pFSH + 600 IU eCG	8.05 ± 3.8 ^b	4.82 ^d	82
Suffolk	eCG, 750–1000 IU, single injection	7.7 ± 1.4	3.5 ± 1.6	-	-	^[15]
	FSH, 20–24 mg, multiple injections	8.4 ± 0.4	5.3 ± 0.5	-	-
Xinji fine wool	FSH at the rate of 60, 50, and 30 IU per injection on days 1, 2, and 3	9.67 ± 1.93	7.85 ± 2.4	-	4.52 ± 2.5 ^b	^[16]
	150 mg Folltropin-V, twice daily at 35, 25, and 15 mg per injection on days 1, 2, and 3	12.47 ± 1.5	9.27 ± 1.8	-	7.86 ± 1.75 ^a

¹ OR, ovulation rate; ² ER, embryos recovered; ³ FR(%), fertilization rate; ⁴ TRR, transferrable embryos. Values with different superscripts within the column show a significant difference at p < 0.05.

To cope with these shortcomings, various researchers have attempted to replace the classical FSH multiple injection protocol with either a single FSH injection ^[17]^[18]^[19]^[20] or a single injection of FSH in combination with eCG ^[1]^[6]^[21]^[22]^[23]^[24]. However, no significant difference between single and multiple injections has been found for ovulation rate (10.2 vs. 10.8), embryonic recovery (9.9 vs. 10.5), or fertilized embryos (5.2 vs. 3.9); however, the proportion of good-quality embryos (5.1 vs. 2.9) was reported to be comparatively higher in the simplified than the conventional superovulation protocol (Table 1) ^[7].

Furthermore, a comparable ovulation rate (14.5 vs. 15.9, p > 0.05) and embryonic recovery (11.3 vs. 10.7, p > 0.05) was obtained for the FSH plus eCG single injection and FSH multiple doses, respectively ^[6]. FSH plus eCG in a single injection not only resulted in a greater proportion of viable embryos, but also the advanced onset of estrus and LH peak ^[1]. A few successful simplified attempts have also been made in cattle ^[25]^[26]^[27]^[28]^[29] and goats ^[30].

These findings indicate that FSH in combination with eCG in a single injection could produce an acceptable ovarian response. However, due to the lack of studies on this simplified superovulation protocol in sheep, the endocrinological basis of this protocol remains poorly understood.

2. eCG and Superovulation Response

Equine chorionic gonadotropin (eCG) is extensively used for superstimulation in sheep. This hormone is typically injected via a single dose for 1–2 days before estrus synchronization ^[13]. Although eCG is cost-effective and can easily be applied to an open flock with minimal bodily stress ^[31], dose-dependent responses may lead to an increased number of persistent large follicles ^[31] and premature corpus luteum regression ^[32]. Furthermore, it also influences the pattern of steroidal hormone synthesis, thus disrupting sperm and gamete transport, as well as preimplantation embryo development ^[33]. To potentiate the ovarian response, the combination of eCG and FSH has been applied, and increased ovulation rate (14.2 vs. 6.2; p < 0.05) and embryonic recovery (5.2 vs. 1.0; p < 0.05) was observed ^[13]. A significantly higher ovulation rate (13.8 vs. 6.2) and embryo recovery (8.4 vs. 1.0) has been reported for FSH/eCG combined administration compared to FSH dissolved in saline divided into four equal doses ^[1]. No significant difference in the mean number of corpora lutea (CL; 8.7 vs. 9.4), transferable rate (85.3% vs. 88.8%),or degenerated embryos (5.4% vs. 4.8%) was observed; however, the average number of transferable embryos (5.5 and 6.6; p < 0.001) was significantly higher in the eCG plus FSH group than with eCG alone ^[34]. Similarly, eCG at a dose rate of 800 IU with 12 or 16 mg FSH (multiple injections) obtained a higher ovarian response than with eCG alone (14.8 vs. 19.1 vs. 3.5; p < 0.05) ^[35]. These results demonstrate that the administration of eCG combined with FSH in a simplified form can provide a high superovulatory response as compared to the single injection of eCG, injected 1–2 days before sponge removal.

3. Other Rarely Used Hormones

Some investigators also tested alternative gonadotropin preparations for superovulation in sheep, such as HAP, hMG, GnRH, and hCG. For example, HAP, obtained from the pituitaries of slaughter material, has been reported to induce a comparable response to p-FSH conventional protocols in sheep ^[36]^[37]^[38]. This hormone reduced the excess of large, non-ovulatory follicles, and also improved the quality of transferrable embryos ^[33].

In addition, hMG has been shown to produce a comparable ovulation rate (10 vs. 9.9; p > 0.05), rate of transferable embryos (84% vs. 80%), and fertilization rate (86% vs. 95%; (p > 0.05) to that of FSH ^[39]. Similar comparable responses of hMG with FSH have also been obtained ^[40], and in one case, hMG produced higher ovulation rates and improved embryo quality than obtained through FSH ^[33]. However, this hormone has not been extensively utilized for superstimulation due to its high cost ^[41].

Several researchers injected GnRH after sponge removal in order to improve the synchronization of the ovulation of follicles when injecting FSH or eCG. It has been reported that the association of longer progesterone exposure with GnRH administration is an alternative method to improve oocyte fertilization rates, particularly during fixed-time insemination ^[42]. Similarly, GnRH administration 24h after sponge withdrawal increased ewes ovulation rate when treated with eCG. The number of recovered embryos from ewes treated with eCG plus GnRH (4.3 vs. 1.06; p < 0.05) was higher than in ewes treated with eCG alone ^[43]. Similarly, in Santa Inês ewes, donors were synchronized with an insertion of a progesterone controlled-internal drug release (CIDR) device for 14 days, exchanging with a new CIDR on day 7, and administered PGF_2α. On day 12, the superovulatory treatment was initiated using 133 mg of pFSH (Folltropin) at eight decreasing doses twice daily. On day 14, at the time of CIDR removal, ewes were divided into the following three groups: control group (progesterone device withdrawn at day 14); 12h P4 group (progesterone device maintained for an additional 12 h, i.e., until day 14.5); 12h P4 GnRH group (progesterone maintained for an additional 12 h, i.e., until day 14.5, plus a GnRH agonist). The results showed that a higher fertilization rate (77% vs. 34% vs. 41%; p > 0.05) was found in the group of ewes with progesterone devices maintained for 14.5 days plus a GnRH agonist during the last FSH injection, than the other two groups ^[42]. In addition, GnRH administration at the end of superovulation using FSH resulted in greater synchronization between the first and last ovulation events ^[42]. Similarly, at the end of the superovulation protocol, the administration of GnRH increased the fertilization rate, which ultimately enhanced the proportion of viable embryos ^[44].

A short-term protocol has been described, consisting of intravaginal sponges inserted for six days in Santa Inês ewes. On day 5, 300 IU of eCG and 37.5 μgd-cloprostenol were injected. The GnRH agonist at 24 h showed no benefits; however, using a GnRH agonist at 36 h more efficiently synchronized ovulation and promoted the desired environment, with the absence of dominant follicles after ovulation. Therefore, combining a GnRH agonist at 36 h after sponge removal, as in the short-term protocol, with the start of superovulatory treatment at 80 h, may be recommended in ewes. The GnRH agonist at 24 h compared to 36 h after sponge removal showed no estrus response (0.0% vs. 78.0%) ^[45]. The GnRH at 36 h after sponge removal efficiently synchronizes ovulation in ewes treated with FSH due to the improved synchrony in ovulation, promoting the absence of the dominant follicles, which improves fertilization rate and increases the production of viable embryos ^[44].

hCG is structurally similar to LH, and has been shown to increase total CL weight in ewes ^[46]. One explanation for this could be that hCG administration during the early luteal stage encouraged supplementary CL formation ^[47]. Moreover, administering hCG and vaginal sponges has been shown to have positive effects on lambing rates ^[48].

References

Simonetti, L.; Forcada, F.; Rivera, O.; Carou, N.; Alberio, R.; Abecia, J.; Palacin, I. Simplified superovulatory treatments in Corriedale ewes. Anim. Reprod. Sci. 2008, 104, 227–237.
Wang, X.; El-Gayar, M.; Knight, P.; Holtz, W. The long-term effect of active immunization against inhibin in goats. Theriogenology 2009, 71, 318–322.
Bettencourt, E.M.; Bettencourt, C.M.; e Silva, J.C.; Ferreira, P.; Manito, C.I.; Matos, C.M.; Romão, R.J.; Rocha, A. Effect of season and gonadotrophin preparation on superovulatory response and embryo quality in Portuguese Black Merinos. Small Rumin. Res. 2008, 74, 134–139.
Quan, F.; Zhang, Z.; An, Z.; Hua, S.; Zhao, X.; Zhang, Y. Multiple factors affecting superovulation in Poll Dorset in China. Reprod. Domest. Anim. 2011, 46, 39–44.
Shi, J.-M.; Yi, J.-Y.; Tian, X.-Z.; Wang, F.; Lian, Z.-X.; Han, H.-B.; Fu, J.-C.; Lv, W.-F.; Liu, G.-S. Effects of seasonal changes on the ovulation rate and embryo quality in superovulated Black Suffolk ewes. Neuroendocrinol. Lett. 2015, 36, 330–336.
Forcada, F.; Amer-Meziane, M.A.; Abecia, J.; Maurel, M.-C.; Cebrián-Pérez, J.; Muiño-Blanco, T.; Asenjo, B.; Vázquez, M.; Casao, A. Repeated superovulation using a simplified FSH/eCG treatment for in vivo embryo production in sheep. Theriogenology 2011, 75, 769–776.
Panyaboriban, S.; Suwimonteerabutr, J.; Swangchan-Uthai, T.; Tharasanit, T.; Suthikrai, W.; Suadsong, S.; Techakumphu, M. A simplified superovulation protocol using split-single administration of Folltropin®-V in hyaluronan: Application to purebred sheep. Vet. Med. 2018, 63, 321–328.
Chumchai, R.; Ratsiri, T.; Ratchamak, R.; Vongpralub, T.; Boonkum, W.; Chankitisakul, V. Ovarian responses and FSH profiles at superovulation with a single epidural administration of gonadotropin in the Thai-Holstein crossbreed. Anim. Reprod. 2021, 18, e20210053.
Lunenfeld, B.; Bilger, W.; Longobardi, S.; Alam, V.; D’Hooghe, T.; Sunkara, S.K. The development of gonadotropins for clinical use in the treatment of infertility. Front. Endocrinol. 2019, 10, 429.
Holtz, W. Embryo transfer in the goat—A review. DTW. Dtsch. Tierarztl. Wochenschr. 1996, 103, 293–297.
Azawi, O.I.; Al-Mola, M. A study on superovulation using FSH and eCG in Awassi ewes. Trop. Anim. Health Prod. 2010, 42, 799–801.
Cueto, M.; Gibbons, A.; Pereyra-Bonnet, F.; Silvestre, P.; González-Bulnes, A. Effects of Season and Superovulatory Treatment on Embryo Yields in Fine-Wool Merinos Maintained Under Field Conditions. Reprod. Domest. Anim. 2011, 46, 770–775.
Blanco, M.; Simonetti, L.; Rivera, O. Embryo production and progesterone profiles in ewes superovulated with different hormonal treatments. Small Rumin. Res. 2003, 47, 183–191.
Leoni, G.; Bogliolo, L.; Pintus, P.; Ledda, S.; Naitana, S. Sheep embryos derived from FSH/eCG treatment have a lower in vitro viability after vitrification than those derived from FSH treatment. Reprod. Nutr. Dev. 2001, 41, 239–246.
Armstrong, D.; Evans, G. Factors influencing success of embryo transfer in sheep and goats. Theriogenology 1983, 19, 31–42.
Wu, W.; Yang, M.; Gong, P.; Wang, F.; Tian, Y.; Xu, X.; Fu, X.; Tian, K.; Guo, Z. Effect of two follicle stimulating hormone (FSH) preparations and simplified superovulatory treatments on superovulatory response in Xinji fine-wool sheep. Afr. J. Biotechnol. 2011, 10, 15834–15837.
Sebastian, A.L.; Cognie, Y.; Cocero, M.; De La Fuente, J.; Poulin, N. Effect of season and duration of FSH treatment on embryo production in sheep. Theriogenology 1990, 34, 175–180.
Dattena, M.; Vespignani, S.; Branca, A.; Gallus, M.; Ledda, S.; Naitana, S.; Cappai, P. Superovulatory response and quality of embryos recovered from anestrus ewes after a single injection of porcine FSH dissolved in polyvinylpyrrolidone. Theriogenology 1994, 42, 235–239.
Meinecke-Tillman, S.; Lewalski, H.; Meinecke, B. Induction of superovulation in Merinolandshaf ewes after single or multiple FSH injectons. Reprod. Domest. Anim. 1993, 28, 433–442.
Peebles, I.; Kidd, J. Single treatment superovulation in the cashmere goat using porcine follicle stimulating hormone. Theriogenology 1994, 41, 271.
Maxwell, W.; Wilson, H. Superovulation and embryo recovery in adult and maiden ewes treated with single and multiple injections of pituitary extract. Proc. Aust. Soc. Reprod. Biol. 1990, 22, 15.
Watanabe, H.; Miyamoto, A.; Okada, M.; Ishida, N.; Kimura, H.; Fukui, Y. A simple superovulation method of a single injection of follicle-stimulating hormone combined with equine chorionic gonadotropin for superovulation of Suffolk ewes during the breeding season: I. Effects of different treatments on the endocrine profiles. J. Reprod. Dev. 1998, 44, 169–176.
Yamada, A.; Kawana, M.; Tamura, Y.; Miyamoto, A.; Fukui, Y. Effect of single or multiple injection of follicle stimulating hormone combined with pregnant mare serum gonadotropin on superovulatory response, and normal and freezable embryos in ewes. J. Reprod. Dev. 1996, 42, 81–87.
Evans, G. Superovulation and embryo recovery in Merino ewes. Theriogenology 1994, 41, 192.
Chasombat, J.; Sakhong, D.; Nagai, T.; Parnpai, R.; Vongpralub, T. Superstimulation of follicular growth in Thai native heifers by a single administration of follicle stimulating hormone dissolved in polyvinylpyrrolidone. J. Reprod. Dev. 2012, 59, 214.
Tríbulo, A.; Rogan, D.; Tribulo, H.; Tribulo, R.; Alasino, R.V.; Beltramo, D.; Bianco, I.; Mapletoft, R.J.; Bó, G.A. Superstimulation of ovarian follicular development in beef cattle with a single intramuscular injection of Folltropin-V. Anim. Reprod. Sci. 2011, 129, 7–13.
Kimura, K.; Hirako, M.; Iwata, H.; Aoki, M.; Kawaguchi, M.; Seki, M. Successful superovulation of cattle by a single administration of FSH in aluminum hydroxide gel. Theriogenology 2007, 68, 633–639.
Bo, G.; Hockley, D.; Nasser, L.; Mapletoft, R. Superovulatory response to a single subcutaneous injection of Folltropin-V in beef cattle. Theriogenology 1994, 42, 963–975.
Yamamoto, M.; Ooe, M.; Kawaguchi, M.; Suzuki, T. Superovulation in the cow with a single intramuscular injection of FSH dissolved in polyvinylpyrrolidone. Theriogenology 1994, 41, 747–755.
Batt, P.; Killeen, I.; Cameron, A. Use of single or multiple injections of FSH in embryo collection programmes in goats. Reprod. Fertil. Dev. 1993, 5, 49–56.
D’Alessandro, A.; Martemucci, G.; Toteda, F.; Gambacorta, M.; Manchisi, A. Superovulation and embryo production in ewes using a commercial p-FSH. Small Rumin. Res. 1996, 19, 255–261.
Senthilkumar, P.; Rajasundaram, R.; Selvaraju, M.; Kathiresan, D. Effect of inclusion of norgestomet ear implants in the goat superovulationregimen. Indian Vet. J. 1998, 75, 595–597.
Gonzalez, F.; Calero, P.; Beckers, J.-F. Induction of superovulation in domestic ruminants. In Biotechnology in Animal Husbandry; Springer: Berlin/Heidelberg, Germany, 2001; pp. 209–223.
Cseh, S.; Solti, L. Studies on factors affecting superovulation and embryo transfer in Hungarian Merino ewes. Acta Vet. Hung. 2001, 49, 431–441.
Ryan, J.; Hunton, J.; Maxwell, W. Increased production of sheep embryos following superovulation of Merino ewes with a combination of pregnant mare serum gonadotrophin and follicle stimulating hormone. Reprod. Fertil. Dev. 1991, 3, 551–560.
Moore, N.; Shelton, J. Egg transfer in sheep. Effect of degree of synchronization between donor and recipient, age of egg, and site of transfer on the survival of transferred eggs. J. Reprod. Fertil. 1964, 7, 145–152.
Moore, N. Fertilization in ewes treated with progesterone and equine anterior pituitary extract. J. Endocrinol. 1970, 46, 121–122.
Boland, M.; Crosby, T.; Gordon, I. Ovarian response in ewes following horse anterior pituitary extract and progestagen treatment. Anim. Reprod. Sci. 1983, 6, 119–127.
Schiewe, M.; Howard, J.; Goodrowe, K.; Stuart, L.; Wildt, D. Human menopausal gonadotropin induces ovulation in sheep, but embryo recovery after prostaglandin F2α synchronization is compromised by premature luteal regression. Theriogenology 1990, 34, 469–486.
Baldassarre, A.; Aste, F.; Argerich, M.; de Matos, D. Comparative study between human menopausic gonadotrophin (HMG) and hipofisisary follicle stimulating hormone (FSH-P) for superovulation in sheep. In Proceedings of the 12th International Congress on Animal Reproduction, The Hague, The Netherlands, 23–27 August 1992; pp. 182–183.
Bó, G.A.; Mapletoft, R.J. Superstimulation of ovarian follicles in cattle: Gonadotropin treatment protocols and FSH profiles. Theriogenology 2020, 150, 353–359.
Brasil, O.; Moreira, N.; Júnior, G.S.; Silva, B.; Mariante, A.; Ramos, A. Superovulatory and embryo yielding in sheep using increased exposure time to progesterone associated with a GnRH agonist. Small Rumin. Res. 2016, 136, 54–58.
Azawi, O. A new technique for nonsurgical embryo recovery in superovulated ewes treated with estradiol and oxytocin. Al-Qadisiyah J. Vet. Med. Sci. 2011, 10, 36–44.
Menchaca, A.; Vilariño, M.; Pinczak, A.; Kmaid, S.; Saldaña, J. Progesterone treatment, FSH plus eCG, GnRH administration, and Day 0 Protocol for MOET programs in sheep. Theriogenology 2009, 72, 477–483.
Balaro, M.; Fonseca, J.; Barbosa, T.; Souza-Fabjan, J.; Figueira, L.; Teixeira, T.; Carvalheira, L.; Brandão, F. Potential role for GnRH in the synchronization of follicular emergence before the superovulatory Day 0 protocol. Domest. Anim. Endocrinol. 2016, 54, 10–14.
Schmitt, E.-P.; Diaz, T.; Barros, C.; De la Sota, R.; Drost, M.; Fredriksson, E.; Staples, C.; Thorner, R.; Thatcher, W. Differential response of the luteal phase and fertility in cattle following ovulation of the first-wave follicle with human chorionic gonadotropin or an agonist of gonadotropin-releasing hormone. J. Anim. Sci. 1996, 74, 1074–1083.
Rajamahendran, R.; Sianangama, P. Effect of human chorionic gonadotrophin on dominant follicles in cows: Formation of accessory corpora lutea, progesterone production and pregnancy rates. Reproduction 1992, 95, 577–584.
Kaya, S.; Kaçar, C.; Kaya, D.; Aslan, S. The effectiveness of supplemental administration of progesterone with GnRH, hCG and PGF2α on the fertility of Tuj sheep during the non-breeding season. Small Rumin. Res. 2013, 113, 365–370.

© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Agriculture, Dairy & Animal Science

Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :

View Times: 516

Update Date: 21 Apr 2022

Table of Contents

Video Upload Options

Confirm

1. FSH and Superovulatory Response

2. eCG and Superovulation Response

3. Other Rarely Used Hormones

References